Table 11: Discriminant validity: Heterotrait-Monotrait Ratio (HTMT).
–
|
Clinical Pathways |
Clinical Pathways |
DP |
DPL |
EC |
IC |
IE |
IS |
TCE |
TS |
Clinical Pathways |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Clinical Pathways |
0.752 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
DP |
0.812 |
0.703 |
- |
- |
- |
- |
- |
- |
- |
- |
DPL |
0.783 |
0.707 |
0.788 |
- |
- |
- |
- |
- |
- |
- |
EC |
0.660 |
0.609 |
0.576 |
0.568 |
- |
- |
- |
- |
- |
- |
IC |
0.709 |
0.536 |
0.562 |
0.504 |
0.721 |
- |
- |
- |
- |
- |
IE |
0.650 |
0.672 |
0.682 |
0.585 |
0.497 |
0.559 |
- |
- |
- |
- |
IS |
0.716 |
0.769 |
0.769 |
0.690 |
0.657 |
0.631 |
0.679 |
|
- |
- |
TCE |
0.866 |
0.799 |
0.828 |
0.788 |
0.753 |
0.717 |
0.625 |
0.802 |
- |
- |
TS |
0.839 |
0.786 |
0.795 |
0.695 |
0.698 |
0.676 |
0.709 |
0.784 |
0.865 |
- |